Heron Neutron Medical Corp. (TPE:7799)

Taiwan · Delayed Price · Currency is TWD

502.00

+45.00 (9.85%)

At close: Sep 17, 2026

Market Cap	79.31B -32.8%
Revenue (ttm)	11.69M +482.1%
Net Income	-479.38M
EPS	-3.11
Shares Out	158.00M
PE Ratio	n/a
Forward PE	191.71
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,515,618
Open	462.50
Previous Close	457.00
Day's Range	461.50 - 502.00
52-Week Range	300.00 - 860.00
Beta	n/a
Analysts	Strong Buy
Price Target	886.67 (+76.63%)
Earnings Date	Oct 16, 2026

About Heron Neutron Medical

Heron Neutron Medical Corp. develops, manufactures, and sells medical instruments. It offers accelerator-based boron neutron capture therapy solutions, including neutron source target system, accelerator system, target system, beam shaping assembly, treatment control system, treatment planning system, and patient positioning system; and ACSI cyclotron products. The company was founded in 2017 and is based in Zhubei, Taiwan. [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2017

Employees 104

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 7799

Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 4 analysts, the average rating for 7799 stock is "Strong Buy." The 12-month stock price target is $886.67, which is an increase of 76.63% from the latest price.

Price Target

$886.67

(76.63% upside)

Analyst Consensus: Strong Buy

Stock Forecasts